GW Pharma

GW Pharmaceuticals is a biopharmaceutical company that develops and markets cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It offers Epidiolex, oral medicine for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms.

Morgan Prestwich were retained and placed quite a number of positions for the company globally:
- Medical Director US
- Medical Director Europe
- Global VP Regulatory Affairs US
- European Marketing Director